Shanghai Institute of Immunology, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China.
J Immunol. 2014 Apr 1;192(7):3021-8. doi: 10.4049/jimmunol.1302934. Epub 2014 Feb 21.
The inhibitory FcγR FcγRIIB is widely expressed on B cells, dendritic cells (DCs), and myeloid effector cells and modulates a variety of Ab-driven in vivo functions. Although it has been established that FcγRIIB plays an important role in the maintenance of peripheral tolerance, the responsible cell-specific FcγRIIB expression remains to be determined. In this study, we generated mice with selective deletion of FcγRIIB in B cells, DCs, and myeloid effector cells and evaluated these novel strains in models of tolerance and autoimmune diseases. Our results demonstrate that mice with selective deletion of FcγRIIB expression in B cells and DCs have increased Ab and T cell responses, respectively, and display enhanced susceptibility to disease in distinct models, suggesting that FcγRIIB expression in distinct cellular populations contributes to the maintenance of peripheral tolerance through different mechanisms.
抑制性 FcγRIIB 广泛表达于 B 细胞、树突状细胞(DC)和髓系效应细胞上,并调节多种抗体(Ab)驱动的体内功能。虽然已经确定 FcγRIIB 在维持外周耐受方面发挥着重要作用,但负责细胞特异性 FcγRIIB 表达的机制仍有待确定。在这项研究中,我们生成了 B 细胞、DC 和髓系效应细胞中 FcγRIIB 选择性缺失的小鼠,并在耐受和自身免疫性疾病模型中评估了这些新型品系。我们的结果表明,B 细胞和 DC 中 FcγRIIB 表达缺失的小鼠分别具有增强的 Ab 和 T 细胞反应,并在不同模型中表现出易感性增加,这表明不同细胞群体中 FcγRIIB 的表达通过不同机制有助于维持外周耐受。